{"id":"https://openalex.org/W3181843645","doi":"https://doi.org/10.1158/1538-7445.am2021-1285","title":"Abstract 1285: In vitro characterization of sotorasib and other RAS \u2018His95-groove' binders and investigation of resistance mechanisms","display_name":"Abstract 1285: In vitro characterization of sotorasib and other RAS \u2018His95-groove' binders and investigation of resistance mechanisms","publication_year":2021,"publication_date":"2021-07-01","ids":{"openalex":"https://openalex.org/W3181843645","doi":"https://doi.org/10.1158/1538-7445.am2021-1285","mag":"3181843645"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2021-1285","doi":"https://doi.org/10.1158/1538-7445.am2021-1285","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2021-1285","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053466224","display_name":"Anne Y. Saiki","orcid":"https://orcid.org/0000-0003-3913-1860","observed_orcids":["https://orcid.org/0000-0003-3913-1860"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Y. Saiki","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017832650","display_name":"Deanna Mohn","orcid":"https://orcid.org/0000-0001-5748-7591","observed_orcids":["https://orcid.org/0000-0001-5748-7591"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deanna Mohn","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yu Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Li","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060909099","display_name":"Tao Osgood","orcid":"https://orcid.org/0009-0000-4393-0441","observed_orcids":["https://orcid.org/0009-0000-4393-0441"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Osgood","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067185109","display_name":"Karen Rex","orcid":"https://orcid.org/0009-0005-8948-2134","observed_orcids":["https://orcid.org/0009-0005-8948-2134"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Rex","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100646199","display_name":"Huiling Wang","orcid":"https://orcid.org/0000-0002-8537-1008","observed_orcids":["https://orcid.org/0000-0002-8537-1008"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hui-Ling Wang","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061423929","display_name":"Ivonne Archibeque","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivonne Archibeque","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher Mohr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Mohr","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028917512","display_name":"Pragathi Achanta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pragathi Achanta","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012009728","display_name":"Andres Plata Stapper","orcid":"https://orcid.org/0000-0003-3183-9645","observed_orcids":["https://orcid.org/0000-0003-3183-9645"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andres Plata Stapper","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036549237","display_name":"Aaron S. Rapaport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron S. Rapaport","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016057308","display_name":"Jude R. Canon","orcid":"https://orcid.org/0009-0005-3149-4247","observed_orcids":["https://orcid.org/0009-0005-3149-4247"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jude Canon","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007920990","display_name":"Victor J. Cee","orcid":"https://orcid.org/0000-0002-7714-397X","observed_orcids":["https://orcid.org/0000-0002-7714-397X"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor J. Cee","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033094493","display_name":"Brian A. Lanman","orcid":"https://orcid.org/0000-0002-8768-7188","observed_orcids":["https://orcid.org/0000-0002-8768-7188"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian A. Lanman","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110436589","display_name":"James Russell Lipford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Russell Lipford","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"13_Supplement","first_page":"1285","last_page":"1285"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.027300000190734863,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.020999999716877937,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c-inhibitors","display_name":"KRAS G12C inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.6209999918937683},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7099999785423279},{"id":"https://openalex.org/keywords/cgas-sting-pathway","display_name":"cGAS-STING pathway","score":0.8700000047683716},{"id":"https://openalex.org/keywords/mhc-class-i-expression","display_name":"MHC class I expression","score":0.9399999976158142},{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.75}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.783003568649292},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49707749485969543},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.4965680241584778},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.47767314314842224},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4656223952770233},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4253268837928772},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42059171199798584},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4109940528869629},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3806627094745636},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3667527437210083},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3402177691459656},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3313155770301819},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2814195156097412},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.17007160186767578},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.11481702327728271},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11323699355125427},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.08815997838973999}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2021-1285","doi":"https://doi.org/10.1158/1538-7445.am2021-1285","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2021-1285","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6899999976158142,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4390985936","https://openalex.org/W7212015026","https://openalex.org/W4396539454","https://openalex.org/W3178145722","https://openalex.org/W7111526675","https://openalex.org/W4282932914","https://openalex.org/W4386413915","https://openalex.org/W4409634038","https://openalex.org/W3193116257","https://openalex.org/W7161945900"],"abstract_inverted_index":{"Abstract":[0],"Sotorasib":[1,21],"(formerly":[2],"known":[3],"as":[4,53,318,320],"AMG":[5],"510),":[6],"the":[7,63,117,121,127,134,143,173,179,202,231,239,283,342,401],"first-in-class":[8],"KRASG12C":[9,24,57,102,199,223,252],"inhibitor,":[10],"has":[11],"demonstrated":[12,105,235],"promising":[13],"clinical":[14],"efficacy":[15],"in":[16,62,126,157,238,341],"KRAS":[17,162,214,296],"p.G12C":[18,163,215],"mutant":[19],"cancers.":[20],"binds":[22],"to":[23,55,79,195,222,251,260,277,288,335],"through":[25,257,300],"a":[26,30,106,169,272],"unique":[27,321],"interaction":[28],"with":[29,69,182,230],"surface":[31],"groove":[32],"created":[33],"by":[34],"side-chain":[35],"rotation":[36],"of":[37,42,75,109,123,133,137,145,193,198,248,263,266,295,326,331,385,394,400],"histidine":[38],"95":[39],"(His95).":[40],"Characterization":[41,265],"sotorasib":[43,76,278,311,336,386],"and":[44,51,82,88,93,113,153,160,216,245,279,315,387,392,413],"other":[45,56,101,154,388],"His95-groove":[46,186],"binders":[47,187,391],"revealed":[48,168],"enhanced":[49],"potency":[50,110,314],"selectivity":[52],"compared":[54],"inhibitor":[58,103,233],"scaffolds,":[59],"which":[60,90,211],"bind":[61],"P2":[64,128],"pocket":[65],"via":[66],"hydrogen":[67],"bonding":[68],"His95.":[70],"The":[71],"novel":[72],"binding":[73,122],"mode":[74],"also":[77,255,280],"translated":[78],"similar":[80],"biochemical":[81],"cellular":[83,135],"potencies":[84],"against":[85,111,323],"both":[86,213],"NRASG12C":[87,112],"HRASG12C,":[89,114],"encode":[91],"leucine":[92],"glutamine":[94],"at":[95],"position":[96],"95,":[97],"respectively.":[98],"In":[99,201,328,382],"contrast,":[100],"scaffolds":[104],"dramatic":[107],"loss":[108],"suggesting":[115],"that":[116,282,308],"alternate":[118],"residues":[119],"impacted":[120],"these":[124,267,305],"molecules":[125],"pocket.":[129],"To":[130],"extend":[131],"characterization":[132,330,384],"effects":[136,180,240],"RAS":[138,389],"\u2018His95-groove'":[139,390],"binders,":[140],"we":[141],"analyzed":[142],"expression":[144],"major":[146],"histocompatibility":[147],"complex":[148],"(MHC)":[149],"class":[150,197],"I":[151],"proteins":[152],"inflammatory":[155],"markers":[156],"multiple":[158],"human":[159],"murine":[161],"cell":[164,209,269],"lines.":[165],"These":[166],"studies":[167],"partial":[170],"dependency":[171],"on":[172,241],"cytosolic":[174],"DNA-sensing":[175],"(cGAS/STING)":[176],"pathway":[177],"for":[178,190,274,404],"observed":[181],"some":[183],"markers.":[184],"Finally,":[185],"were":[188,254],"evaluated":[189],"potential":[191,332],"mechanisms":[192,334,396],"resistance":[194,221,250,284,333,395],"this":[196],"inhibitors.":[200],"mouse":[203],"syngeneic":[204],"Lewis":[205],"Lung":[206],"Carcinoma":[207],"(LL/2)":[208],"line,":[210],"carries":[212],"NRAS":[217],"p.Q61H":[218],"mutations,":[219],"intrinsic":[220],"inhibition":[224,253],"was":[225,285],"observed,":[226],"but":[227,291],"combination":[228,339],"treatment":[229],"MEK":[232],"trametinib":[234],"synergistic":[236],"improvement":[237],"viability.":[242],"MIA":[243],"PaCa-2":[244],"NCI-H358":[246],"models":[247],"acquired":[249],"developed":[256],"long-term":[258],"exposure":[259,276],"high":[261],"concentrations":[262],"sotorasib.":[264],"resistant":[268],"lines":[270],"indicated":[271],"requirement":[273],"constant":[275],"showed":[281],"not":[286],"due":[287],"genetic":[289],"alterations":[290],"involved":[292],"either":[293],"overexpression":[294],"or":[297],"bypass":[298],"signaling":[299],"alternative":[301],"pathways.":[302],"Taken":[303],"together,":[304],"data":[306],"demonstrate":[307],"His95-binders":[309],"like":[310],"display":[312],"superior":[313],"off-target":[316],"selectivity,":[317],"well":[319],"activity":[322],"all":[324],"versions":[325],"RASG12C.":[327],"addition,":[329],"will":[337],"inform":[338],"strategies":[340],"clinic.":[343],"Citation":[344],"Format:":[345],"Anne":[346],"Y.":[347],"Saiki,":[348],"Deanna":[349],"Mohn,":[350],"Yu":[351],"Li,":[352],"Tao":[353],"Osgood,":[354],"Karen":[355],"Rex,":[356],"Hui-Ling":[357],"Wang,":[358],"Ivonne":[359],"Archibeque,":[360],"Christopher":[361],"Mohr,":[362],"Pragathi":[363],"Achanta,":[364],"Andres":[365],"Plata":[366],"Stapper,":[367],"Aaron":[368],"S.":[369],"Rapaport,":[370],"Jude":[371],"Canon,":[372],"Victor":[373],"J.":[374,379],"Cee,":[375],"Brian":[376],"A.":[377],"Lanman,":[378],"Russell":[380],"Lipford.":[381],"vitro":[383],"investigation":[393],"[abstract].":[397],"In:":[398],"Proceedings":[399],"American":[402],"Association":[403],"Cancer":[405,419],"Research":[406],"Annual":[407],"Meeting":[408],"2021;":[409],"2021":[410],"Apr":[411],"10-15":[412],"May":[414],"17-21.":[415],"Philadelphia":[416],"(PA):":[417],"AACR;":[418],"Res":[420],"2021;81(13_Suppl):Abstract":[421],"nr":[422],"1285.":[423]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2021-07-19T00:00:00"}